Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Revenue of Neuland Laboratories Limited (NEULANDLAB.NS)
Revenue in 2023 (TTM): $184.66 M
According to Neuland Laboratories Limited's latest financial reports the company's current revenue (TTM) is $184.66 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Neuland Laboratories Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $184.66 M | $97.72 M | $56.26 M | $47.56 M | $35.55 M |
| 2022 | $141.13 M | $68.41 M | $33.36 M | $25.56 M | $19.37 M |
| 2021 | $109.63 M | $44.05 M | $17.14 M | $9.73 M | $7.56 M |
| 2020 | $109.5 M | $43.31 M | $19.3 M | $12.48 M | $9.55 M |
| 2019 | $89.78 M | $33.17 M | $12.53 M | $6.27 M | $1.92 M |
| 2018 | $76.53 M | $24.03 M | $7.33 M | $2.41 M | $1.95 M |
| 2017 | $60.75 M | $22.86 M | $6.51 M | $1.65 M | $1.43 M |
| 2016 | $67.86 M | $29.24 M | $12.74 M | $5.85 M | $3.89 M |
| 2015 | $60.42 M | $22.99 M | $9.74 M | $4.98 M | $3.24 M |
| 2014 | $55.06 M | $19.56 M | $8.01 M | $2.93 M | $1.89 M |
| 2013 | $55.17 M | $20.22 M | $9.09 M | $4.09 M | $3.18 M |
| 2012 | $54.57 M | $16.96 M | $7.82 M | $2.24 M | $1.64 M |
| 2011 | $53.14 M | $14.85 M | $5.68 M | $98.45 K | $303.42 K |
| 2010 | $46.64 M | $9.56 M | $5.66 M | $585.04 K | $626.63 K |
| 2009 | $32.99 M | $7.19 M | $3.1 M | $-1,162,740 | $-818,088 |
| 2008 | $36.34 M | $7.19 M | $3.5 M | $1.73 M | $1.41 M |